Advancing Diagnostic Excellence
Explore our diagnostic innovations
At Unilabs, we continuously expand our diagnostic portfolio with innovative solutions that support healthcare professionals in making informed clinical decisions. From advanced biomarker testing to personalised molecular diagnostics, discover how our latest innovations contribute to more precise diagnostics, tailored patient management and better-informed care.
Oncology | Molecular diagnostics
Signatera™
Personalised molecular residual disease (MRD) testing to support recurrence-risk assessment and treatment monitoring in oncology.
Neurology | Laboratory diagnostics
Elecsys® pTau217
A plasma-based biomarker test to support the assessment of amyloid pathology in patients undergoing evaluation for Alzheimer's disease.